Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial-Reference-Cited by-同舟云学术

Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial

Published:2012-11 Issue:11 Volume:18 Page:1716-1726
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Finke Jürgen,Schmoor Claudia,Bethge Wolfgang A.,Ottinger Hellmut D.,Stelljes Matthias,Zander Axel R.,Volin Liisa,Heim Dominik A.,Schwerdtfeger Rainer,Kolbe Karin,Mayer Jiri,Maertens Johan A.,Linkesch Werner,Holler Ernst,Koza Vladimir,Bornhäuser Martin,Einsele Hermann,Bertz Hartmut,Grishina Olga,Socié Gérard

Funder

Fresenius Biotech GmbH

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. The EBMT activity survey 2009: trends over the past 5 years;Baldomero;Bone Marrow Transplant,2011

2. Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia;Sorror;Biol Blood Marrow Transplant,2005

3. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia;Arora;J Clin Oncol,2009

4. Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match;Dehn;Biol Blood Marrow Transplant,2008

5. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse;Weisdorf;Biol Blood Marrow Transplant,2009

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Important Is Unrelated Donor Human Leukocyte Antigen Disparity in the Post-Transplant Cyclophosphamide Era?;Journal of Clinical Oncology;2024-08-21

2. Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study);Bone Marrow Transplantation;2024-03-16

3. Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study);2023-11-30

4. The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation;Expert Review of Hematology;2023-11-06

5. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults;Cochrane Database of Systematic Reviews;2023-06-21